EUVIMEDEUVIMED entdecken
Crossref

Mitochondrial‐Targeted Copper Delivery for Cuproptosis‐Based Synergistic Cancer Therapy

Jinpeng Deng, Huilan Zhuang, Sijie Shao, Xuemei Zeng, Panpan Xue, Tingjie Bai, Xiaoman Wang, Shijie Shangguan, Yuanchun Chen, Shuangqian Yan, Wei Huang iD

Advanced Healthcare Materials · 2024-07 · 13 (18)

DOI: 10.1002/adhm.202304522 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Healthcare Materials, online erschienen am 31.03.2024. Verfasst von Jinpeng Deng und 10 weiteren Autor:innen. Beteiligte Einrichtung: The Straits Laboratory of Flexible Electronics (SLoFE), Straits Institute of Flexible Electronics (SIFE Future Technologies), Fujian Normal Universit…. Hauptthemen laut MEDLINE: Copper, Mitochondria, Metal-Organic Frameworks. Die Arbeit wurde bisher 72-mal zitiert (Crossref) und nennt 42 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Science and Technology Planning Project of Fujian Province, Cultivation Plan for Science and Technology Innovation Team from the College of Life Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cuproptosis is dependent on mitochondrial respiration modulation by targeting lipoylated tricarboxylic acid cycle (TCA) cycle proteins, showing great potential in cancer treatment. However, the specific release of copper ions at mitochondrial is highly needed and still a major challenge to trigger cellular cuproptosis. Herein, a metal‐organic framework‐based nanoplatform (ZCProP) is designed for mitochondrial‐targeted and ATP/pH‐responsive Cu 2+ and prodigiosin release. The released Cu 2+ promotes aggregation of lipoylated protein and loss of Fe‐S cluster protein, resulting in cell cuproptosis. In the meanwhile, Cu 2+ can concert with prodigiosin to induce mitochondrial dysfunction and DNA damage and enhance cell cuproptosis. Furthermore, this nanoplatform has an ability to deplete glutathione, which not only further promotes cuproptosis but also triggers cell ferroptosis by the suppression of glutathione peroxidase 4, an anti‐ferroptosis protein. Collectively, the designed ZCProP nanoplatform can responsively release cargos at mitochondrial and realize a conspicuous therapeutic efficacy through a cuproptosis‐mediated concerted effect. Along with its excellent biocompatibility, this nanoplatform may provide a novel therapeutic modality paradigm to boost cancer therapeutic strategies based on cuproptosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CopperMitochondriaMetal-Organic FrameworksHumansNeoplasmsAnimalsFerroptosisCell Line, TumorMice

Stichwörter der Autor:innen

MOFsZIF‐90cuproptosisferroptosismitochondrial‐targeting

Substanzen

CopperMetal-Organic Frameworks

Autor:innen und Institutionen

  • The Straits Laboratory of Flexible Electronics (SLoFE), Straits Institute of Flexible Electronics (SIFE Future Technologies), Fujian Normal University, Fuzhou, Fujian, 350117, China.
  • Key Laboratory of Microbial Pathogenesis and Interventions of Fujian Province University, Key Laboratory of Innate Immune Biology of Fujian Province, Biomedical Research Center of South China, College of Life Sciences,…
  • Frontiers Science Center for Flexible Electronics (FSCFE), MIIT Key Laboratory of Flexible Electronics (KLoFE), Northwestern Polytechnical University, Xi'an, Shanxi, 710072, China.

ORCID-Profile: Wei Huang

Förderung

  • National Natural Science Foundation of China
  • Science and Technology Planning Project of Fujian Province
  • Cultivation Plan for Science and Technology Innovation Team from the College of Life Sciences
  • Fujian Normal University

Zitieren

APA

Deng, J., Zhuang, H., Shao, S., Zeng, X., Xue, P., Bai, T., Wang, X., Shangguan, S., Chen, Y., Yan, S., & Huang, W. (2024). Mitochondrial‐Targeted Copper Delivery for Cuproptosis‐Based Synergistic Cancer Therapy. Advanced Healthcare Materials, 13(18). https://doi.org/10.1002/adhm.202304522

Vancouver

Deng J, Zhuang H, Shao S, Zeng X, Xue P, Bai T, et al. Mitochondrial‐Targeted Copper Delivery for Cuproptosis‐Based Synergistic Cancer Therapy. Advanced Healthcare Materials. 2024;13(18). doi:10.1002/adhm.202304522

BibTeX
@article{Deng2024,
  author = {Deng, Jinpeng and Zhuang, Huilan and Shao, Sijie and Zeng, Xuemei and Xue, Panpan and Bai, Tingjie and Wang, Xiaoman and Shangguan, Shijie and Chen, Yuanchun and Yan, Shuangqian and Huang, Wei},
  title = {Mitochondrial‐Targeted Copper Delivery for Cuproptosis‐Based Synergistic Cancer Therapy},
  journal = {Advanced Healthcare Materials},
  year = {2024},
  volume = {13},
  number = {18},
  doi = {10.1002/adhm.202304522}
}
Kostenlos starten →